Glycoprotein A (GARP) in children who outgrow food allergy
Main Article Content
Keywords
Children, Food allergy, Glycoprotein a, GARP
Abstract
Background: There is little understanding of the mechanisms by which food allergy (FA) develops into persistent disease, or by which symptoms it regresses. Food allergy is a major health problem in developed countries, where the prevalence reaches up to 6% in children and 3% in the adult population.
Objective: Children with food allergy remission (FAR) and those without FAR below five years of age, were compared 7-10 years with respect to clinical data and expression of glycoprotein A repetitions predominant (GARP) on peripheral blood mononuclear cells.
Methods: Forty children with FAR and 40 children without FAR at age 7-10, in whom FA was previously diagnosed at age below five years were evaluated. In this prospective study, demographic and clinical data were taken, patients were classified as atopic based on history and serum specific IgE (sIgE) for a specific allergen. Blood samples were obtained from all patients to assess expression of GARP.
Results: We observed higher expression of GARP in children with FAR compared to children without FA (p = 0.005); optimal cut-off for GARP prediction of the remission was 20.1%. Children with FAR and food-specific IgE in serum had higher expression of GARP compared to children with low food specific IgE (<0.35 kU/L). Keeping pets at home decreased, and presence of allergic rhinitis increased ORs for high expression of GARP (hGARP) in our patients.
Conclusion: hGARP (>20.1%) is related with FAR in school children. Allergic rhinitis, and pets at home modify this effect of GARP. Children with allergic rhinitis have less chance of developing remission despite maintaining immune tolerance (hGARP); quite the opposite case with pets at home.
References
2. Sicherer SH. Food allergy. Mt Sinai J Med. 2011;78(Sep-Oct (5)):683-96.
3. Caffarelli C, Ricò S, Varini M, Povesi-Dascola C, Mastrorilli C. Skin prick test and development of tolerance in egg allergy. Pediatr Allergy Immunol. 2016;27(Dec (8)):881-4.
4. Meyer-Martin H, Hahn SA, Beckert H, Belz C, Heinz A, Jonuleit H, et al. GARP inhibits allergic airway inflammation in a humanized mouse model. Allergy. 2016;71(9):1274-83.
5. Bihouée T, Bouchaud G, Chesné J, Lair D, Rolland-Debord C, Braza F, et al. Food allergy enhances allergic asthma in mice. Respir Res. 2014;15(142).
6. Vermeulen EM, Koplin JJ, Dharmage SC, Gurrin LC, Peters RL, McWilliam V, et al. Food allergy is an important risk factor for childhood asthma, irrespective of whether it resolves. J Allergy Clin Immunol Pract. 2018;6(4):1336-41.
7. Savenije OE, Kerkhof M, Koppelman GH, Postma DS, et al. Predicting who will have asthma at school age among preschool children. J Allergy Clin Immunol. 2012;130:325-31.
8. Martin PE, Matheson MC, Gurrin L, Burgess JA, Osborne N, Lowe AJ, et al. Childhood eczema and rhinitis predict atopic but not nonatopic adult asthma: a prospective cohort study over 4 decades. J Allergy Clin Immunol. 2011;127(6):1473-9.
9. Vrbova M, Dorociakova P, Vyskovsky R, Palkovicova Murinova L, Ciznar P, Rausova K, et al. Dynamics of allergy development during the first 5 years of life. Eur J Pediatr. 2018. Jun 22.
10. Neeland MR, Koplin JJ, Dang TD, Dharmage SC, Tang ML, Prescott SL, et al. Early life innate immune signatures of persistent food allergy. J Allergy Clin Immunol. 2018;142(Sep (3)):857-64.
11. Hahn SA, Stahl HF, Becker C, Correll A, Schneider FJ, Tuettenberg A, Jonuleit H, et al. Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4+ T cells. Blood. 2013;122(7):1182-91.
12. Nousbeck J, Irvine AD. Atopic dermatitis according to GARP: new mechanistic insights in disease pathogenesis. J Invest Dermatol. 2016;136, 2340e2341.
